{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:05:08Z","timestamp":1790359508127,"version":"4.1.0"},"reference-count":172,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,12,9]],"date-time":"2010-12-09T00:00:00Z","timestamp":1291852800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s10096-010-1122-9","type":"journal-article","created":{"date-parts":[[2010,12,7]],"date-time":"2010-12-07T23:09:59Z","timestamp":1291763399000},"page":"483-498","source":"Crossref","is-referenced-by-count":11,"title":["Peroxisome proliferator activating receptor (PPAR) in cerebral malaria (CM): a novel target for an additional therapy"],"prefix":"10.1007","volume":"30","author":[{"given":"S.","family":"Balachandar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Katyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,12,9]]},"reference":[{"key":"1122_CR1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.molbiopara.2009.03.006","volume":"166","author":"CA Moxon","year":"2009","unstructured":"Moxon CA, Heyderman RS, Wassmer SC (2009) Dysregulation of coagulation in cerebral malaria. Mol Biochem Parasitol 166:99\u2013108","journal-title":"Mol Biochem Parasitol"},{"key":"1122_CR2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00018-009-0211-3","volume":"67","author":"D Cox","year":"2010","unstructured":"Cox D, McConkey S (2010) The role of platelets in the pathogenesis of cerebral malaria. Cell Mol Life Sci 67:557\u2013568","journal-title":"Cell Mol Life Sci"},{"key":"1122_CR3","doi-asserted-by":"crossref","first-page":"6260","DOI":"10.1074\/jbc.M809756200","volume":"284","author":"R Hora","year":"2009","unstructured":"Hora R, Bridges DJ, Craig A, Sharma A (2009) Erythrocytic casein kinase II regulates cytoadherence of Plasmodium falciparum-infected red blood cells. J Biol Chem 284:6260\u20136269","journal-title":"J Biol Chem"},{"key":"1122_CR4","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.micinf.2007.07.011","volume":"9","author":"C Jurzynski","year":"2007","unstructured":"Jurzynski C, Gysin J, Pouvelle B (2007) CD44, a signal receptor for the inhibition of the cytoadhesion of CD36-binding Plasmodium falciparum-infected erythrocytes by CSA-binding infected erythrocytes. Microbes Infect 9:1463\u20131470","journal-title":"Microbes Infect"},{"key":"1122_CR5","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1128\/IAI.01852-06","volume":"75","author":"B Pouvelle","year":"2007","unstructured":"Pouvelle B, Matarazzo V, Jurzynski C, Nemeth J, Ramharter M, Rougon G, Gysin J (2007) Cell adhesion molecule, a new cytoadhesion receptor for Plasmodium falciparum-infected erythrocytes capable of aggregation. Infect Immun 75:3516\u20133522","journal-title":"Infect Immun"},{"key":"1122_CR6","first-page":"8","volume":"169","author":"S Picot","year":"2009","unstructured":"Picot S, Bienvenu AL, Konate S, Sissoko S, Barry A, Diarra E, Bamba K, Djimd\u00e9 A, Doumbo OK (2009) Safety of epoietin\u2013quinine drug combination in children with cerebral malaria in Mali. Malar J 169:8\u201324","journal-title":"Malar J"},{"key":"1122_CR7","doi-asserted-by":"crossref","unstructured":"Santos-Magalh\u00e3es NS, Mosqueira VC (2010) Nanotechnology applied to the treatment of malaria. Adv Drug Deliv Rev 18:560\u2013575","DOI":"10.1016\/j.addr.2009.11.024"},{"key":"1122_CR8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1006\/cyto.2001.0845","volume":"14","author":"M Odeh","year":"2001","unstructured":"Odeh M (2001) The role of tumour necrosis factor-alpha in the pathogenesis of complicated falciparum malaria. Cytokine 14:8\u201311","journal-title":"Cytokine"},{"key":"1122_CR9","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s00436-008-0891-x","volume":"102","author":"S Specht","year":"2008","unstructured":"Specht S, Sarite SR, Hauber I, Hauber J, G\u00f6rbig UF, Meier C, Bevec D, Hoerauf A, Kaiser A (2008) The guanylhydrazone CNI-1493: an inhibitor with dual activity against malaria-inhibition of host cell pro-inflammatory cytokine release and parasitic deoxyhypusine synthase. Parasitol Res 102:1177\u20131184","journal-title":"Parasitol Res"},{"key":"1122_CR10","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/iub.237","volume":"61","author":"AP Singh","year":"2009","unstructured":"Singh AP, Surolia N, Surolia A (2009) Triclosan inhibit the growth of the late liver-stage of Plasmodium. IUBMB Life 61:923\u2013928","journal-title":"IUBMB Life"},{"key":"1122_CR11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4149\/neo_2009_04_279","volume":"56","author":"A Konieczna","year":"2009","unstructured":"Konieczna A, Lichnovka R, Erdosova B, Ehrmann J (2009) The role of PPARs in MDR\u2014a lesson from embryonic development. Neoplasma 56:279\u2013283","journal-title":"Neoplasma"},{"key":"1122_CR12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pharmthera.2009.06.011","volume":"124","author":"D Bishop-Bailey","year":"2009","unstructured":"Bishop-Bailey D, Bystrom J (2009) Emerging roles of peroxisome proliferator-activated receptor-\u03b2\/\u03b4 in inflammation. Pharmacol Ther 124:141\u2013150","journal-title":"Pharmacol Ther"},{"key":"1122_CR13","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1523\/JNEUROSCI.5529-08.2009","volume":"29","author":"M Sobrado","year":"2009","unstructured":"Sobrado M, Pereira MP, Ballesteros I, Hurtado O, Fern\u00e1ndez-L\u00f3pez D, Pradillo JM, Caso JR, Vivancos J, Nombela F, Serena J, Lizasoain I, Moro MA (2009) Synthesis of lipoxin A4 by 5-lipoxygenase mediates PPAR gamma-dependent, neuroprotective effects of rosiglitazone in experimental stroke. J Neurosci 29:3875\u20133884","journal-title":"J Neurosci"},{"key":"1122_CR14","first-page":"975","volume":"234","author":"S Ramanan","year":"2010","unstructured":"Ramanan S, Zhao W, Riddle DR, Robbins ME (2010) Role of PPARs in radiation-induced brain injury. PPAR Res 234:975","journal-title":"PPAR Res"},{"key":"1122_CR15","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/labinvest.2008.20","volume":"88","author":"J Lin","year":"2008","unstructured":"Lin J, Chen A (2008) Activation of peroxisome proliferator-activated receptor-gamma by curcumin blocks the signaling pathways for PDGF and EGF in hepatic stellate cells. Lab Invest 88:529\u2013540","journal-title":"Lab Invest"},{"key":"1122_CR16","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1136\/gut.2009.186528","volume":"59","author":"A Baghdasaryan","year":"2010","unstructured":"Baghdasaryan A, Claudel T, Kosters A, Gumhold J, Silbert D, Th\u00fcringer A, Leski K, Fickert P, Karpen SJ, Trauner M (2010) Curcumin improves sclerosing cholangitis in Mdr2-\/- mice by inhibition of cholangiocyte inflammatory response and portal myofibroblast proliferation. Gut 59:521\u2013530","journal-title":"Gut"},{"key":"1122_CR17","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1007\/s00018-003-2347-x","volume":"60","author":"F Gimenez","year":"2003","unstructured":"Gimenez F, Barraud de Lagerie S, Fernandez C, Pino P, Mazier D (2003) Tumor necrosis factor alpha in the pathogenesis of cerebral malaria. Cell Mol Life Sci 60:1623\u20131635","journal-title":"Cell Mol Life Sci"},{"key":"1122_CR18","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/eji.200939996","volume":"40","author":"T Reimer","year":"2010","unstructured":"Reimer T, Shaw MH, Franchi L, Coban C, Ishii KJ, Akira S, Horii T, Rodriguez A, N\u00fa\u00f1ez G (2010) Experimental cerebral malaria progresses independently of the Nlrp3 inflammasome. Eur J Immunol 40:64\u201369","journal-title":"Eur J Immunol"},{"key":"1122_CR19","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/cyto.b.20141","volume":"70","author":"P Butthep","year":"2006","unstructured":"Butthep P, Wanram S, Pattanapanyasat K, Vattanaviboon P, Fucharoen S, Wilairat P (2006) Cytoadherence between endothelial cells and P. falciparum infected and noninfected normal and thalassemic red blood cells. Cytom B Clin Cytom 70:432\u2013442","journal-title":"Cytom B Clin Cytom"},{"key":"1122_CR20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4269\/ajtmh.1990.43.15","volume":"43","author":"RJ Howard","year":"1990","unstructured":"Howard RJ, Handunnetti SM, Hasler T, Gilladoga A, de Aguiar JC, Pasloske BL, Morehead K, Albrecht GR, van Schravendijk MR (1990) Surface molecules on Plasmodium falciparum-infected erythrocytes involved in adherence. Am J Trop Med Hyg 43:15\u201329","journal-title":"Am J Trop Med Hyg"},{"key":"1122_CR21","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/QCO.0b013e32830ef5cf","volume":"21","author":"JB Weinberg","year":"2008","unstructured":"Weinberg JB, Lopansri BK, Mwaikambo E, Granger DL (2008) Arginine, nitric oxide, carbon monoxide, and endothelial function in severe malaria. Curr Opin Infect Dis 21:468\u2013475","journal-title":"Curr Opin Infect Dis"},{"key":"1122_CR22","first-page":"122","volume":"61","author":"K Ohnishi","year":"2009","unstructured":"Ohnishi K (2009) Cerebral malaria. Brain Nerve 61:122\u2013128","journal-title":"Brain Nerve"},{"key":"1122_CR23","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1179\/136485905X51508","volume":"99","author":"H Armah","year":"2005","unstructured":"Armah H, Dodoo AK, Wiredu EK, Stiles JK, Adjei AA, Gyasi RK, Tettey Y (2005) High-level cerebellar expression of cytokines and adhesion molecules in fatal, paediatric, cerebral malaria. Ann Trop Med Parasitol 99:629\u2013647","journal-title":"Ann Trop Med Parasitol"},{"key":"1122_CR24","first-page":"8","volume":"157","author":"M Prato","year":"2008","unstructured":"Prato M, Gallo V, Giribaldi G, Arese P (2008) Phagocytosis of haemozoin (malarial pigment) enhances metalloproteinase-9 activity in human adherent monocytes: role of IL-1beta and 15-HETE. Malar J 157:8\u201317","journal-title":"Malar J"},{"key":"1122_CR25","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1365-3024.2008.01053.x","volume":"30","author":"E Belnoue","year":"2008","unstructured":"Belnoue E, Potter SM, Rosa DS, Mauduit M, Gr\u00fcner AC, Kayibanda M, Mitchell AJ, Hunt NH, R\u00e9nia L (2008) Control of pathogenic CD8+ T cell migration to the brain by IFN-gamma during experimental cerebral malaria. Parasite Immunol 30:544\u2013553","journal-title":"Parasite Immunol"},{"key":"1122_CR26","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/eji.200737906","volume":"38","author":"PE Steen Van den","year":"2008","unstructured":"Van den Steen PE, Deroost K, Van Aelst I, Geurts N, Martens E, Struyf S, Nie CQ, Hansen DS, Matthys P, Van Damme J, Opdenakker G (2008) CXCR3 determines strain susceptibility to murine cerebral malaria by mediating T lymphocyte migration toward IFN-gamma-induced chemokines. Eur J Immunol 38:1082\u20131095","journal-title":"Eur J Immunol"},{"key":"1122_CR27","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1365-2990.1999.00188.x","volume":"25","author":"H Brown","year":"1999","unstructured":"Brown H, Hien TT, Day N, Mai NT, Chuong LV, Chau TT, Loc PP, Phu NH, Bethell D, Farrar J, Gatter K, White N, Turner G (1999) Evidence of blood\u2013brain barrier dysfunction in human cerebral malaria. Neuropathol Appl Neurobiol 25:331\u2013340","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1122_CR28","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ijpara.2006.02.005","volume":"36","author":"V Combes","year":"2006","unstructured":"Combes V, Coltel N, Faille D, Wassmer SC, Grau GE (2006) Cerebral malaria: role of microparticles and platelets in alterations of the blood\u2013brain barrier. Int J Parasitol 36:541\u2013546","journal-title":"Int J Parasitol"},{"key":"1122_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0163-7258(98)00008-4","volume":"79","author":"CRJC Newton","year":"1998","unstructured":"Newton CRJC, Krishna S (1998) Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment. Pharmacol Ther 79:1\u201353","journal-title":"Pharmacol Ther"},{"key":"1122_CR30","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/0140-6736(92)93295-X","volume":"340","author":"IA Clark","year":"1992","unstructured":"Clark IA, Rockett KA, Cowden WB (1992) Possible central role of nitric oxide in conditions clinically similar to cerebral malaria. Lancet 340:894\u2013896","journal-title":"Lancet"},{"key":"1122_CR31","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1136\/jnnp.69.4.433","volume":"69","author":"CR Newton","year":"2000","unstructured":"Newton CR, Hien TT, White N (2000) Cerebral malaria. J Neurol Neurosurg Psychiatry 69:433\u2013441","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1122_CR32","unstructured":"Omari AA, Garner P (2007) Malaria: severe, life-threatening. Clin Evid (Online) July 2007, p 913"},{"key":"1122_CR33","doi-asserted-by":"crossref","first-page":"631","DOI":"10.4269\/ajtmh.2009.09-0204","volume":"81","author":"AJ Helmers","year":"2009","unstructured":"Helmers AJ, Gowda DC, Kain KC, Liles WC (2009) Statins fail to improve outcome in experimental cerebral malaria and potentiate Toll-like receptor-mediated cytokine production by murine macrophages. Am J Trop Med Hyg 81:631\u2013637","journal-title":"Am J Trop Med Hyg"},{"key":"1122_CR34","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/01.LAB.0000028822.94883.8A","volume":"82","author":"PF Piguet","year":"2002","unstructured":"Piguet PF, Kan CD, Vesin C (2002) Role of the tumor necrosis factor receptor 2 (TNFR2) in cerebral malaria in mice. Lab Invest 82:1155\u20131166","journal-title":"Lab Invest"},{"key":"1122_CR35","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1590\/S1413-86702008000500006","volume":"12","author":"G Awasthi","year":"2008","unstructured":"Awasthi G, Singh S, Dash AP, Das A (2008) Genetic characterization and evolutionary inference of TNF-alpha through computational analysis. Braz J Infect Dis 12:374\u2013379","journal-title":"Braz J Infect Dis"},{"key":"1122_CR36","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.exppara.2010.04.016","volume":"126","author":"LM Randall","year":"2010","unstructured":"Randall LM, Engwerda CR (2010) TNF family members and malaria: old observations, new insights and future directions. Exp Parasitol 126:326\u2013331","journal-title":"Exp Parasitol"},{"key":"1122_CR37","doi-asserted-by":"crossref","first-page":"e2608","DOI":"10.1371\/journal.pone.0002608","volume":"9","author":"D Togbe","year":"2008","unstructured":"Togbe D, de Sousa PL, Fauconnier M, Boissay V, Fick L, Scheu S, Pfeffer K, Menard R, Grau GE, Doan BT, Beloeil JC, Renia L, Hansen AM, Ball HJ, Hunt NH, Ryffel B, Quesniaux VF (2008) Both functional LTbeta receptor and TNF receptor 2 are required for the development of experimental cerebral malaria. PLoS ONE 9:e2608","journal-title":"PLoS ONE"},{"key":"1122_CR38","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.4049\/jimmunol.1000944","volume":"185","author":"FH Amante","year":"2010","unstructured":"Amante FH, Haque A, Stanley AC, Rivera Fde L, Randall LM, Wilson YA, Yeo G, Pieper C, Crabb BS, de Koning-Ward TF, Lundie RJ, Good MF, Pinzon-Charry A, Pearson MS, Duke MG, McManus DP, Loukas A, Hill GR, Engwerda CR (2010) Immune-mediated mechanisms of parasite tissue sequestration during experimental cerebral malaria. J Immunol 185:3632\u20133642","journal-title":"J Immunol"},{"key":"1122_CR39","doi-asserted-by":"crossref","first-page":"e1001021","DOI":"10.1371\/journal.ppat.1001021","volume":"29","author":"R Jambou","year":"2010","unstructured":"Jambou R, Combes V, Jambou MJ, Weksler BB, Couraud PO, Grau GE (2010) Plasmodium falciparum adhesion on human brain microvascular endothelial cells involves transmigration-like cup formation and induces opening of intercellular junctions. PLoS Pathog 29:e1001021","journal-title":"PLoS Pathog"},{"key":"1122_CR40","doi-asserted-by":"crossref","first-page":"14509","DOI":"10.1073\/pnas.0806727105","volume":"105","author":"RJ Lundie","year":"2008","unstructured":"Lundie RJ, de Koning-Ward TF, Davey GM, Nie CQ, Hansen DS, Lau LS, Mintern JD, Belz GT, Schofield L, Carbone FR, Villadangos JA, Crabb BS, Heath WR (2008) Blood-stage Plasmodium infection induces CD8+ T lymphocytes to parasite-expressed antigens, largely regulated by CD8alpha\u2009+\u2009dendritic cells. Proc Natl Acad Sci USA 105:14509\u201314514","journal-title":"Proc Natl Acad Sci USA"},{"key":"1122_CR41","first-page":"1057","volume":"145","author":"GD Turner","year":"1994","unstructured":"Turner GD, Morrison H, Jones M, Davis TM, Looareesuwan S, Buley ID, Gatter KC, Newbold CI, Pukritayakamee S, Nagachinta B et al (1994) An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration. Am J Pathol 145:1057\u20131069","journal-title":"Am J Pathol"},{"key":"1122_CR42","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0165-5728(02)00114-5","volume":"128","author":"JB Dietrich","year":"2002","unstructured":"Dietrich JB (2002) The adhesion molecule ICAM-1 and its regulation in relation with the blood\u2013brain barrier. J Neuroimmunol 128:58\u201368","journal-title":"J Neuroimmunol"},{"key":"1122_CR43","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S1286-4579(99)80513-9","volume":"1","author":"N Favre","year":"1999","unstructured":"Favre N, Da Laperousaz C, Ryffel B, Weiss NA, Imhof BA, Rudin W, Lucas R, Piguet PF (1999) Role of ICAM-1 (CD54) in the development of murine cerebral malaria. Microbes Infect 1:961\u2013968","journal-title":"Microbes Infect"},{"key":"1122_CR44","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0092-8674(92)90206-R","volume":"68","author":"CF Ockenhouse","year":"1992","unstructured":"Ockenhouse CF, Betageri R, Springer TA, Staunton DE (1992) Plasmodium falciparum-infected erythrocytes bind ICAM-1 at a site distinct from LFA-1, Mac-1, and human rhinovirus. Cell 68:63\u201369","journal-title":"Cell"},{"key":"1122_CR45","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ijpara.2006.02.007","volume":"36","author":"L R\u00e9nia","year":"2006","unstructured":"R\u00e9nia L, Potter SM, Mauduit M, Rosa DS, Kayibanda M, Deschemin JC, Snounou G, Gr\u00fcner AC (2006) Pathogenic T cells in cerebral malaria. Int J Parasitol 36:547\u2013554","journal-title":"Int J Parasitol"},{"key":"1122_CR46","doi-asserted-by":"crossref","first-page":"e245","DOI":"10.1371\/journal.pmed.0020245","volume":"2","author":"SC Wassmer","year":"2005","unstructured":"Wassmer SC, Cianciolo GJ, Combes V, Grau GE (2005) Inhibition of endothelial activation: a new way to treat cerebral malaria? PLoS Med 2:e245","journal-title":"PLoS Med"},{"key":"1122_CR47","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-2567.1997.00297.x","volume":"92","author":"C Monso-Hinard","year":"1997","unstructured":"Monso-Hinard C, Lou JN, Behr C, Juillard P, Grau GE (1997) Expression of major histocompatibility complex antigens on mouse brain microvascular endothelial cells in relation to susceptibility to cerebral malaria. Immunology 92:53\u201359","journal-title":"Immunology"},{"key":"1122_CR48","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1365-2249.2000.01196.x","volume":"120","author":"L Chen","year":"2000","unstructured":"Chen L, Zhang Z, Sendo F (2000) Neutrophils play a critical role in the pathogenesis of experimental cerebral malaria. Clin Exp Immunol 120:125\u2013133","journal-title":"Clin Exp Immunol"},{"key":"1122_CR49","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1383-5769(01)00063-0","volume":"50","author":"L Chen","year":"2001","unstructured":"Chen L, Sendo F (2001) Cytokine and chemokine mRNA expression in neutrophils from CBA\/NSlc mice infected with Plasmodium berghei ANKA that induces experimental cerebral malaria. Parasitol Int 50:139\u2013143","journal-title":"Parasitol Int"},{"key":"1122_CR50","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0883-9441(94)90032-9","volume":"9","author":"RJ Korthuis","year":"1994","unstructured":"Korthuis RJ, Anderson DC, Granger DN (1994) Role of neutrophil-endothelial cell adhesion in inflammatory disorders. J Crit Care 9:47\u201371","journal-title":"J Crit Care"},{"key":"1122_CR51","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jneuroim.2005.02.009","volume":"163","author":"TF Pais","year":"2005","unstructured":"Pais TF, Chatterjee S (2005) Brain macrophage activation in murine cerebral malaria precedes accumulation of leukocytes and CD8+ T cell proliferation. J Neuroimmunol 163:73\u201383","journal-title":"J Neuroimmunol"},{"key":"1122_CR52","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/13550280701258084","volume":"3","author":"A Szklarczyk","year":"2007","unstructured":"Szklarczyk A, Stins M, Milward EA, Ryu H, Fitzsimmons C, Sullivan D, Conant K (2007) Glial activation and matrix metalloproteinase release in cerebral malaria. J Neurovirol 3:2\u201310","journal-title":"J Neurovirol"},{"key":"1122_CR53","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1046\/j.1365-2249.1998.00586.x","volume":"112","author":"JA Kurtzhals","year":"1998","unstructured":"Kurtzhals JA, Reimert CM, Tette E, Dunyo SK, Koram KA, Akanmori BD, Nkrumah FK, Hviid L (1998) Increased eosinophil activity in acute Plasmodium falciparum infection\u2014association with cerebral malaria. Clin Exp Immunol 112:303\u2013307","journal-title":"Clin Exp Immunol"},{"key":"1122_CR54","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1128\/IAI.55.4.877-881.1987","volume":"55","author":"LS Waters","year":"1987","unstructured":"Waters LS, Taverne J, Tai PC, Spry CJ, Targett GA, Playfair JH (1987) Killing of Plasmodium falciparum by eosinophil secretory products. Infect Immun 55:877\u2013881","journal-title":"Infect Immun"},{"key":"1122_CR55","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1046\/j.1365-3156.1999.00426.x","volume":"4","author":"LH Camacho","year":"1999","unstructured":"Camacho LH, Wilairatana P, Weiss G, Mercader MA, Brittenham GM, Looareesuwan S, Gordeuk VR (1999) The eosinophilic response and haematological recovery after treatment for Plasmodium falciparum malaria. Trop Med Int Health 4:471\u2013475","journal-title":"Trop Med Int Health"},{"key":"1122_CR56","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/icb.1992.53","volume":"70","author":"MF Good","year":"1992","unstructured":"Good MF, Currier J (1992) The importance of T cell homing and the spleen in reaching a balance between malaria immunity and immunopathology: the moulding of immunity by early exposure to cross-reactive organisms. Immunol Cell Biol 70:405\u2013410","journal-title":"Immunol Cell Biol"},{"key":"1122_CR57","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ijpara.2006.02.016","volume":"36","author":"NH Hunt","year":"2006","unstructured":"Hunt NH, Golenser J, Chan-Ling T, Parekh S, Rae C, Potter S, Medana IM, Miu J, Ball HJ (2006) Immunopathogenesis of cerebral malaria. Int J Parasitol 36:569\u2013582","journal-title":"Int J Parasitol"},{"key":"1122_CR58","doi-asserted-by":"crossref","first-page":"548","DOI":"10.2353\/ajpath.2007.061033","volume":"171","author":"FH Amante","year":"2007","unstructured":"Amante FH, Stanley AC, Randall LM, Zhou Y, Haque A, McSweeney K, Waters AP, Janse CJ, Good MF, Hill GR, Engwerda CR (2007) A role for natural regulatory T cells in the pathogenesis of experimental cerebral malaria. Am J Pathol 171:548\u2013559","journal-title":"Am J Pathol"},{"key":"1122_CR59","doi-asserted-by":"crossref","first-page":"e3037","DOI":"10.1371\/journal.pone.0003037","volume":"22","author":"GL Suidan","year":"2008","unstructured":"Suidan GL, Mcdole JR, Chen Y, Pirko I, Johnson AJ (2008) Induction of blood brain barrier tight junction protein alterations by CD8 T cells. PLoS ONE 22:e3037","journal-title":"PLoS ONE"},{"key":"1122_CR60","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/(SICI)1098-1136(199702)19:2<91::AID-GLIA1>3.0.CO;2-C","volume":"19","author":"IM Medana","year":"1997","unstructured":"Medana IM, Hunt NH, Chan-Ling T (1997) Early activation of microglia in the pathogenesis of fatal murine cerebral malaria. Glia 19:91\u2013103","journal-title":"Glia"},{"key":"1122_CR61","first-page":"1473","volume":"150","author":"IM Medana","year":"1997","unstructured":"Medana IM, Hunt NH, Chaudhri G (1997) Tumor necrosis factor-alpha expression in the brain during fatal murine cerebral malaria: evidence for production by microglia and astrocytes. Am J Pathol 150:1473\u20131486","journal-title":"Am J Pathol"},{"issue":"4","key":"1122_CR62","doi-asserted-by":"crossref","first-page":"e1000369","DOI":"10.1371\/journal.ppat.1000369","volume":"5","author":"CQ Nie","year":"2009","unstructured":"Nie CQ, Bernard NJ, Norman MU, Amante FH, Lundie RJ, Crabb BS, Heath WR, Engwerda CR, Hickey MJ, Schofield L, Hansen DS (2009) IP-10-mediated T cell homing promotes cerebral inflammation over splenic immunity to malaria infection. PLoS Pathog 5(4):e1000369","journal-title":"PLoS Pathog"},{"issue":"1","key":"1122_CR63","first-page":"257","volume":"150","author":"W Rudin","year":"1997","unstructured":"Rudin W, Eugster HP, Bordmann G, Bonato J, M\u00fcller M, Yamage M, Ryffel B (1997) Resistance to cerebral malaria in tumor necrosis factor-alpha\/beta-deficient mice is associated with a reduction of intercellular adhesion molecule-1 up-regulation and T helper type 1 response. Am J Pathol 150(1):257\u2013266","journal-title":"Am J Pathol"},{"key":"1122_CR64","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.4049\/jimmunol.173.4.2217","volume":"173","author":"MF Bachmann","year":"2004","unstructured":"Bachmann MF, Schwarz K, Wolint P, Meijerink E, Martin S, Manolova V, Oxenius A (2004) Distinct roles for T help and CD40\/CD40 ligand in regulating differentiation of proliferation-competent memory CD8\u2009+\u2009T cells. J Immunol 173:2217\u20132221","journal-title":"J Immunol"},{"key":"1122_CR65","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ijpara.2005.12.005","volume":"36","author":"S Potter","year":"2006","unstructured":"Potter S, Chan-Ling T, Ball HJ, Mansour H, Mitchell A, Maluish L, Hunt NH (2006) Perforin mediated apoptosis of cerebral microvascular endothelial cells during experimental cerebral malaria. Int J Parasitol 36:485\u2013496","journal-title":"Int J Parasitol"},{"key":"1122_CR66","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1128\/IAI.74.1.645-653.2006","volume":"74","author":"SC Wassmer","year":"2006","unstructured":"Wassmer SC, Combes V, Candal FJ, Juhan-Vague I, Grau GE (2006) Platelets potentiate brain endothelial alterations induced by Plasmodium falciparum. Infect Immun 74:645\u2013653","journal-title":"Infect Immun"},{"key":"1122_CR67","doi-asserted-by":"crossref","first-page":"e1000744","DOI":"10.1371\/journal.ppat.1000744","volume":"29","author":"KN Couper","year":"2010","unstructured":"Couper KN, Barnes T, Hafalla JC, Combes V, Ryffel B, Secher T, Grau GE, Riley EM, de Souza JB (2010) Parasite-derived plasma microparticles contribute significantly to malaria infection-induced inflammation through potent macrophage stimulation. PLoS Pathog 29:e1000744","journal-title":"PLoS Pathog"},{"key":"1122_CR68","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1196\/annals.1299.109","volume":"1010","author":"P Pino","year":"2003","unstructured":"Pino P, Vouldoukis I, Dugas N, Hassani-Loppion G, Dugas B, Mazier D (2003) Redox-dependent apoptosis in human endothelial cells after adhesion of Plasmodium falciparum-infected erythrocytes. Ann NY Acad Sci 1010:582\u2013586","journal-title":"Ann NY Acad Sci"},{"key":"1122_CR69","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1124\/jpet.110.165605","volume":"333","author":"I Paterniti","year":"2010","unstructured":"Paterniti I, Esposito E, Mazzon E, Galuppo M, Di Paola R, Bramanti P, Kapoor A, Thiemermann C, Cuzzocrea S (2010) Evidence for the role of peroxisome proliferator-activated receptor-beta\/delta in the development of spinal cord injury. J Pharmacol Exp Ther 333:465\u2013477","journal-title":"J Pharmacol Exp Ther"},{"key":"1122_CR70","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0140-6736(03)12564-0","volume":"361","author":"BK Lopansri","year":"2003","unstructured":"Lopansri BK, Anstey NM, Weinberg JB, Stoddard GJ, Hobbs MR, Levesque MC, Mwaikambo ED, Granger DL (2003) Low plasma arginine concentrations in children with cerebral malaria and decreased nitric oxide production. Lancet 361:676\u2013678","journal-title":"Lancet"},{"key":"1122_CR71","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/364626a0","volume":"364","author":"SA Lipton","year":"1993","unstructured":"Lipton SA, Choi YB, Pan ZH, Lei SZ, Chen HS, Sucher NJ, Loscalzo J, Singel DJ, Stamler JS (1993) A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364:626\u2013632","journal-title":"Nature"},{"key":"1122_CR72","first-page":"1176","volume":"231","author":"FS Machado","year":"2006","unstructured":"Machado FS, Desruisseaux MS, Nagajyothi, Kennan RP, Hetherington HP, Wittner M, Weiss LM, Lee SC, Scherer PE, Tsuji M, Tanowitz HB (2006) Endothelin in a murine model of cerebral malaria. Exp Biol Med Maywood 231:1176\u20131181","journal-title":"Exp Biol Med Maywood"},{"key":"1122_CR73","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s007020070017","volume":"107","author":"CO Enwonwu","year":"2000","unstructured":"Enwonwu CO, Afolabi BM, Salako LO, Idigbe EO, Bashirelah N (2000) Increased plasma levels of histidine and histamine in falciparum malaria: relevance to severity of infection. J Neural Transm 107:1273\u20131287","journal-title":"J Neural Transm"},{"key":"1122_CR74","doi-asserted-by":"crossref","unstructured":"Noedl H, Youry Se, Schaecher K, Smith BL, Socheat D, Fukuda MM (2008) Evidence of artemisinin-resistant malaria in Western Cambodia . N Engl J Med 359;24. www.nejm.org . http:\/\/content.nejm.org\/cgi\/reprint\/359\/24\/2619.pdf . Accessed 24 November 2010","DOI":"10.1056\/NEJMc0805011"},{"key":"1122_CR75","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00436-009-1524-8","volume":"105","author":"M Jensen","year":"2009","unstructured":"Jensen M, Mehlhorn H (2009) Seventy-five years of Resochin\u00ae in the fight against malaria. Parasitol Res 105:609\u2013627","journal-title":"Parasitol Res"},{"key":"1122_CR76","unstructured":"WHO (2009) World malaria report 2009. WHO, Geneva. http:\/\/www.who.int\/malaria\/world_malaria_report_2009\/en\/index.html . Accessed 24 November 2010"},{"key":"1122_CR77","unstructured":"Meremikwu MM, Marson AG (2002) Routine anticonvulsants for treating cerebral malaria. Cochrane Database Syst Rev 2:CD002152"},{"key":"1122_CR78","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2165\/00003495-199039020-00002","volume":"39","author":"DM Panisko","year":"1990","unstructured":"Panisko DM, Keystone JS (1990) Treatment of malaria\u20141990. Drugs 39:160\u2013189","journal-title":"Drugs"},{"key":"1122_CR79","unstructured":"WHO (2005) World malaria report, 2005. WHO, Geneva"},{"key":"1122_CR80","unstructured":"WHO (2010) Guidelines for the treatment of malaria\u20142nd edition. WHO, Geneva"},{"key":"1122_CR81","first-page":"1","volume":"21S3","author":"Committee to Advice on Tropical Medicine and Travel","year":"1995","unstructured":"Committee to Advice on Tropical Medicine and Travel (1995) Canadian recommendations for the prevention and treatment of malaria among international travellers. CCDR 21S3:1\u201318","journal-title":"CCDR"},{"key":"1122_CR82","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/1475-2875-9-227","volume":"9","author":"JH Waknine-Grinberg","year":"2010","unstructured":"Waknine-Grinberg JH, Hunt N, Bentura-Marciano A, McQuillan JA, Chan HW, Chan WC, Barenholz Y, Haynes RK, Golenser J (2010) Artemisone effective against murine cerebral malaria. Malar J 9:227","journal-title":"Malar J"},{"key":"1122_CR83","first-page":"66","volume":"76","author":"L Zamidei","year":"2010","unstructured":"Zamidei L, Durval A, Bettocchi D, Luzzio MG, Bartoloni A, Consales G (2010) Efficacy and safety of quinine-artesunate in an HIV-positive patient with severe falciparum malaria. Minerva Anestesiol 76:66\u201369","journal-title":"Minerva Anestesiol"},{"key":"1122_CR84","first-page":"8","volume":"27","author":"P Lackner","year":"2009","unstructured":"Lackner P, Part A, Burger C, Dietmann A, Broessner G, Helbok R, Reindl M, Schmutzhard E, Beer R (2009) Glatiramer acetate reduces the risk for experimental cerebral malaria: a pilot study. Malar J 27:8\u201336","journal-title":"Malar J"},{"key":"1122_CR85","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/157488407779422285","volume":"2","author":"MI Muniz-Junqueira","year":"2007","unstructured":"Muniz-Junqueira MI (2007) Immunomodulatory therapy associated to anti-parasite drugs as a way to prevent severe forms of malaria. Curr Clin Pharmacol 2:59\u201373","journal-title":"Curr Clin Pharmacol"},{"key":"1122_CR86","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.mehy.2006.04.079","volume":"68","author":"K Chowdhury","year":"2007","unstructured":"Chowdhury K, Bagasra O (2007) An edible vaccine for malaria using transgenic tomatoes of varying sizes, shapes and colors to carry different antigens. Med Hypotheses 68:22\u201330","journal-title":"Med Hypotheses"},{"key":"1122_CR87","doi-asserted-by":"crossref","unstructured":"Jirage D, Keenan SM, Waters NC (2010) Exploring novel targets for antimalarial drug discovery: plasmodial protein kinases. Infect Disord Drug Targets 10(3):134\u2013146","DOI":"10.2174\/187152610791163381"},{"key":"1122_CR88","doi-asserted-by":"crossref","unstructured":"Donaldson T, Kim K (2010) Targeting Plasmodium falciparum purine salvage enzymes: a look at structure-based drug development. Infect Disord Drug Targets 10(3):191\u2013199","DOI":"10.2174\/187152610791163408"},{"key":"1122_CR89","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1128\/IAI.63.4.1173-1175.1995","volume":"63","author":"RJ Allan","year":"1995","unstructured":"Allan RJ, Beattie P, Bate C, Van Hensbroek MB, Morris-Jones S, Greenwood BM, Kwiatkowski D (1995) Strain variation in tumor necrosis factor induction by parasites from children with acute falciparum malaria. Infect Immun 63:1173\u20131175","journal-title":"Infect Immun"},{"key":"1122_CR90","author":"CP Sanchez","year":"2010","unstructured":"Sanchez CP, Dave A, Stein WD, Lanzer M (2010) Transporters as mediators of drug resistance in Plasmodium falciparum. Int J Parasitol. doi: 10.1016\/j.ijpara.2010.04.001","journal-title":"Int J Parasitol"},{"key":"1122_CR91","unstructured":"Bloland PB (2001) Drug resistance in malaria. World Health Organization, Geneva, 534 WHO\/CDC\/DRS\/2001.4"},{"key":"1122_CR92","unstructured":"World Health Organization (2006) Guidelines for the treatment of malaria. WHO, Geneva"},{"key":"1122_CR93","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1128\/CMR.17.1.235-254.2004","volume":"17","author":"AO Talisuna","year":"2004","unstructured":"Talisuna AO, Bloland P, D'Alessandro U (2004) History, dynamics, and public health importance of malaria parasite resistance. Clin Microbiol Rev 17:235\u2013254","journal-title":"Clin Microbiol Rev"},{"key":"1122_CR94","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1475-2875-5-81","volume":"5","author":"Y Jackson","year":"2006","unstructured":"Jackson Y, Chappuis F, Loutan L, Taylor W (2006) Malaria treatment failures after artemisinin-based therapy in three expatriates: could improved manufacturer information help to decrease the risk of treatment failure? Malar J 5:81. doi: 10.1186\/1475-2875-5-81","journal-title":"Malar J"},{"key":"1122_CR95","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJMoa062032","volume":"355","author":"M Laufer","year":"2006","unstructured":"Laufer M, Thesing P, Eddington N, Masonga R, Dzinjalamala F, Takala S, Taylor T, Plowe C (2006) Return of chloroquine antimalarial efficacy in Malawi. N Eng J Med 355:1959\u20131966","journal-title":"N Eng J Med"},{"key":"1122_CR96","first-page":"CD004529","volume":"19","author":"A Osei-Akoto","year":"2005","unstructured":"Osei-Akoto A, Orton L, Owusu-Ofori SP (2005) Atovaquone-proguanil for treating uncomplicated malaria. Cochrane Database Syst Rev 19:CD004529","journal-title":"Cochrane Database Syst Rev"},{"key":"1122_CR97","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1473-3099(07)70187-1","volume":"7","author":"NJ White","year":"2007","unstructured":"White NJ (2007) Cardiotoxicity of antimalarial drugs. Lancet Infect Dis 7:549\u2013558","journal-title":"Lancet Infect Dis"},{"key":"1122_CR98","first-page":"56","volume":"18","author":"V Wiwanitkit","year":"2009","unstructured":"Wiwanitkit V (2009) Headache and malaria: a brief review. Acta Neurol Taiwan 18:56\u201359","journal-title":"Acta Neurol Taiwan"},{"key":"1122_CR99","first-page":"353","volume":"72","author":"J Vedy","year":"1979","unstructured":"Vedy J, Graveline J, Carrica J, Rivaud C, Chanut G (1979) Retinopathy due to 4- aminoquinolines in the prevention of malaria. Bull Soc Pathol Exot Filiales 72:353\u2013357","journal-title":"Bull Soc Pathol Exot Filiales"},{"key":"1122_CR100","doi-asserted-by":"crossref","first-page":"637","DOI":"10.4269\/ajtmh.2001.65.637","volume":"65","author":"S Bertagnolio","year":"2001","unstructured":"Bertagnolio S, Tacconelli E, Camilli G, Tumbarello M (2001) Case report: Retinopathy after malaria prophylaxis with chloroquine. Am J Trop Med Hyg 65:637\u2013638","journal-title":"Am J Trop Med Hyg"},{"key":"1122_CR101","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2165\/00002018-199614030-00001","volume":"14","author":"PA Phillips-Howard","year":"1996","unstructured":"Phillips-Howard PA, Wood D (1996) The safety of antimalarial drugs in pregnancy. Drug Saf 14:131\u2013145","journal-title":"Drug Saf"},{"key":"1122_CR102","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0035-9203(03)90079-4","volume":"97","author":"S M\u00e9rat","year":"2003","unstructured":"M\u00e9rat S, Lambert E, Vincenti-Rouquette I, Gidenne S, Rousseau JM, Brinquin L (2003) Case report: combination artemether-lumefantrine and haemolytic anaemia following a malarial attack. Trans R Soc Trop Med Hyg 97:433\u2013434","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1122_CR103","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0027-9684(15)31445-0","volume":"100","author":"O Busari","year":"2008","unstructured":"Busari O, Busari O (2008) Ventricular fibrillation in a 5-year-old child on therapeutic dose of quinine dihydrochloride infusion for acute malaria. J Natl Med Assoc 100:1063\u20131065","journal-title":"J Natl Med Assoc"},{"key":"1122_CR104","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/BF02811499","volume":"46","author":"S Singhi","year":"1979","unstructured":"Singhi S, Singhi P, Singh M (1979) Extrapyramidal syndrome following chloroquine therapy. Indian J Pediatr 46:58\u201360","journal-title":"Indian J Pediatr"},{"key":"1122_CR105","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ijid.2007.06.015","volume":"12","author":"OA Busari","year":"2008","unstructured":"Busari OA, Oligbu G (2008) Chorea in a 29-year-old Nigerian following antimalarial treatment with artesunate. Int J Infect Dis 12:221\u2013223","journal-title":"Int J Infect Dis"},{"key":"1122_CR106","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/1475-2875-7-179","volume":"7","author":"R G\u00fcrkov","year":"2008","unstructured":"G\u00fcrkov R, Eshetu T, Miranda IB, Berens-Riha N, Mamo Y, Girma T, Krause E, Schmidt M, Hempel JM, L\u00f6scher T (2008) Ototoxicity of artemether\/lumefantrine in the treatment of falciparum malaria: a randomized trial. Malar J 7:179","journal-title":"Malar J"},{"key":"1122_CR107","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.nephro.2008.01.001","volume":"4","author":"F Leroy","year":"2008","unstructured":"Leroy F, Bridoux F, Abou-Ayache R, Belmouaz S, Desport E, Thierry A, Bauwens M, Touchard G (2008) Quinine-induced renal bilateral cortical necrosis. N\u00e9phrol Th\u00e9r 4:181\u2013186","journal-title":"N\u00e9phrol Th\u00e9r"},{"key":"1122_CR108","doi-asserted-by":"crossref","first-page":"e4031","DOI":"10.1371\/journal.pone.0004031","volume":"3","author":"CI Fanello","year":"2008","unstructured":"Fanello CI, Karema C, Avellino P, Bancone G, Uwimana A, Lee SJ, d'Alessandro U, Modiano D (2008) High risk of severe anaemia after chlorproguanil-dapsone\u2009+\u2009artesunate antimalarial treatment in patients with G6PD (A-) deficiency. PLoS ONE 3:e4031","journal-title":"PLoS ONE"},{"key":"1122_CR109","first-page":"426","volume":"49","author":"GB Gupta","year":"2001","unstructured":"Gupta GB, Varma S (2001) Effect of intravenous quinine on capillary glucose levels in malaria. J Assoc Physicians India 49:426\u2013429","journal-title":"J Assoc Physicians India"},{"key":"1122_CR110","first-page":"32","volume":"58","author":"AD Dyan","year":"1998","unstructured":"Dyan AD (1998) Neurotoxicity and artemisinin compounds do the observations in animals justify limitation of clinical use? Med Trop Mars 58:32\u201337","journal-title":"Med Trop Mars"},{"key":"1122_CR111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/157488606775252584","volume":"1","author":"F Nosten","year":"2006","unstructured":"Nosten F, McGready R, d'Alessandro U, Bonell A, Verhoeff F, Menendez C, Mutabingwa T, Brabin B (2006) Antimalarial drugs in pregnancy: a review. Curr Drug Saf 1:1\u201315","journal-title":"Curr Drug Saf"},{"key":"1122_CR112","first-page":"CD001474","volume":"2","author":"HJ Smith","year":"2003","unstructured":"Smith HJ, Meremikwu M (2003) Iron chelating agents for treating malaria. Cochrane Database Syst Rev 2:CD001474","journal-title":"Cochrane Database Syst Rev"},{"key":"1122_CR113","first-page":"CD004387","volume":"18","author":"H Bukirwa","year":"2004","unstructured":"Bukirwa H, Garner P, Critchley J (2004) Chlorproguanil-dapsone for treating uncomplicated malaria. Cochrane Database Syst Rev 18:CD004387","journal-title":"Cochrane Database Syst Rev"},{"key":"1122_CR114","doi-asserted-by":"crossref","unstructured":"Waknine-Grinberg JH, McQuillan JA, Hunt N, Ginsburg H, Golenser J (2010) Modulation of cerebral malaria by fasudil and other immune-modifying compounds. Exp Parasitol 125(2):141\u2013146","DOI":"10.1016\/j.exppara.2010.01.005"},{"key":"1122_CR115","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/cr.2010.13","volume":"20","author":"YX Wang","year":"2010","unstructured":"Wang YX (2010) PPARs: diverse regulators in energy metabolism and metabolic diseases. Cell Res 20:124\u2013137","journal-title":"Cell Res"},{"key":"1122_CR116","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.it.2007.09.003","volume":"28","author":"DS Straus","year":"2007","unstructured":"Straus DS, Glass CK (2007) Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms. Trends Immunol 28:551\u2013558","journal-title":"Trends Immunol"},{"key":"1122_CR117","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/83336","volume":"7","author":"A Chawla","year":"2001","unstructured":"Chawla A, Barak Y, Nagy L, Liao D, Tontonoz P, Evans RM (2001) PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat Med 7:48\u201352","journal-title":"Nat Med"},{"key":"1122_CR118","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0074-7742(09)85013-7","volume":"85","author":"T Maeda","year":"2009","unstructured":"Maeda T, Kishioka S (2009) PPAR and pain. Int Rev Neurobiol 85:165\u2013177","journal-title":"Int Rev Neurobiol"},{"key":"1122_CR119","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.2174\/092986705774462905","volume":"12","author":"R Kostadinova","year":"2005","unstructured":"Kostadinova R, Wahli W, Michalik L (2005) PPARs in diseases: control mechanisms of inflammation. Curr Med Chem 12:2995\u20133009","journal-title":"Curr Med Chem"},{"key":"1122_CR120","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.med.53.082901.104018","volume":"53","author":"J Berger","year":"2002","unstructured":"Berger J, Moller DE (2002) The mechanisms of action of PPARs. Annu Rev Med 53:409\u2013435","journal-title":"Annu Rev Med"},{"key":"1122_CR121","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s11064-005-8341-y","volume":"2005","author":"DS Gelinas","year":"2005","unstructured":"Gelinas DS, McLaurin J (2005) PPAR-alpha expression inversely correlates with inflammatory cytokines IL-1beta and TNF-alpha in aging rats. Neurochem Res 2005:1369\u20131375","journal-title":"Neurochem Res"},{"key":"1122_CR122","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/00001756-200505310-00010","volume":"16","author":"JH Lee","year":"2005","unstructured":"Lee JH, Joe EH, Jou I (2005) PPAR-alpha activators suppress STAT1 inflammatory signaling in lipopolysaccharide-activated rat glia. NeuroReport 16:829\u2013833","journal-title":"NeuroReport"},{"key":"1122_CR123","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/1753944708090924","volume":"2","author":"M Collino","year":"2005","unstructured":"Collino M, Patel NS, Thiemermann C (2005) PPARs as new therapeutic targets for the treatment of cerebral ischemia\/reperfusion injury. Ther Adv Cardiovasc Dis 2:179\u2013197","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"1122_CR124","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1177\/147323000803600421","volume":"36","author":"D Feng","year":"2008","unstructured":"Feng D, Zhang Y, Chen G (2008) Cortical expression of peroxisome proliferator-activated receptor-alpha after human brain contusion. J Int Med Res 36:783\u2013791","journal-title":"J Int Med Res"},{"key":"1122_CR125","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neulet.2005.06.019","volume":"388","author":"VC Besson","year":"2005","unstructured":"Besson VC, Chen XR, Plotkine M, Marchand-Verrecchia C (2005) Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, exerts europrotective effects in traumatic brain injury. Neurosci Lett 388:7\u201312","journal-title":"Neurosci Lett"},{"key":"1122_CR126","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1089\/neu.2006.0216","volume":"24","author":"XR Chen","year":"2007","unstructured":"Chen XR, Besson VC, Palmier B, Garcia Y, Plotkine M, Marchand-Leroux C (2007) Neurological recovery-promoting, anti-inflammatory, and anti-oxidative effects afforded by fenofibrate, a PPAR alpha agonist, in traumatic brain injury. J Neurotrauma 24:1119\u20131131","journal-title":"J Neurotrauma"},{"key":"1122_CR127","doi-asserted-by":"crossref","first-page":"6264","DOI":"10.1523\/JNEUROSCI.23-15-06264.2003","volume":"23","author":"D Deplanque","year":"2003","unstructured":"Deplanque D, Gel\u00e9 P, P\u00e9trault O, Six I, Furman C, Bouly M, Nion S, Dupuis B, Leys D, Fruchart JC, Cecchelli R, Staels B, Duriez P, Bordet R (2003) Peroxisome proliferator-activated receptor-alpha activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment. J Neurosci 23:6264\u20136271","journal-title":"J Neurosci"},{"key":"1122_CR128","doi-asserted-by":"crossref","unstructured":"Morgenweck J, Abdel-Aleem OS, McNamara KC, Donahue RR, Badr MZ, Taylor BK Activation of peroxisome proliferator-activated receptor gamma in brain inhibits inflammatory pain, dorsal horn expression of Fos, and local edema. Neuropharmacology 58(2):337\u2013345","DOI":"10.1016\/j.neuropharm.2009.10.008"},{"key":"1122_CR129","doi-asserted-by":"crossref","first-page":"6742","DOI":"10.4049\/jimmunol.166.11.6742","volume":"166","author":"L Serghides","year":"2001","unstructured":"Serghides L, Kain KC (2001) Peroxisome proliferator-activated receptor gamma-retinoid X receptor agonists increase CD36-dependent phagocytosis of Plasmodium falciparum-parasitized erythrocytes and decrease malaria-induced TNF-alpha secretion by monocytes\/macrophages. J Immunol 166:6742\u20136748","journal-title":"J Immunol"},{"key":"1122_CR130","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jneuroim.2007.07.017","volume":"190","author":"L Klotz","year":"2007","unstructured":"Klotz L, Diehl L, Dani I, Neumann H, von Oppen N, Dolf A, Endl E, Klockgether T, Engelhardt B, Knolle P (2007) Brain endothelial PPARgamma controls inflammation-induced CD4+ T cell adhesion and transmigration in vitro. J Neuroimmunol 190:34\u201343","journal-title":"J Neuroimmunol"},{"key":"1122_CR131","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ijdevneu.2008.01.009","volume":"26","author":"H Sun","year":"2008","unstructured":"Sun H, Huang Y, Yu X, Li Y, Yang J, Li R, Deng Y, Zhao G (2008) Peroxisome proliferator-activated receptor gamma agonist, rosiglitazone, suppresses CD40 expression and attenuates inflammatory responses after lithium pilocarpine-induced status epilepticus in rats. Int J Dev Neurosci 26:505\u2013515","journal-title":"Int J Dev Neurosci"},{"key":"1122_CR132","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.2741\/2802","volume":"13","author":"R Kapadia","year":"2008","unstructured":"Kapadia R, Yi JH, Vemuganti R (2008) Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists. Front Biosci 13:1813\u20131826","journal-title":"Front Biosci"},{"key":"1122_CR133","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.biopsych.2005.01.007","volume":"57","author":"B Garc\u00eda-Bueno","year":"2005","unstructured":"Garc\u00eda-Bueno B, Madrigal JL, Lizasoain I, Moro MA, Lorenzo P, Leza JC (2005) Peroxisome proliferator-activated receptor gamma activation decreases neuroinflammation in brain after stress in rats. Biol Psychiatry 57:885\u2013894","journal-title":"Biol Psychiatry"},{"key":"1122_CR134","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1038\/jcbfm.2009.87","volume":"29","author":"CX Wang","year":"2009","unstructured":"Wang CX, Ding X, Noor R, Pegg C, He C, Shuaib A (2009) Rosiglitazone alone or in combination with tissue plasminogen activator improves ischemic brain injury in an embolic model in rats. J Cereb Blood Flow Metab 29:1683\u20131694","journal-title":"J Cereb Blood Flow Metab"},{"key":"1122_CR135","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.2741\/2802","volume":"13","author":"A Hyong","year":"2008","unstructured":"Hyong A, Kapadia R, Yi JH, Vemuganti R (2008) Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists. Front Biosci 13:1813\u20131826","journal-title":"Front Biosci"},{"key":"1122_CR136","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.brainres.2008.04.025","volume":"1215","author":"A Hyong","year":"2008","unstructured":"Hyong A, Jadhav V, Lee S, Tong W, Rowe J, Zhang JH, Tang J (2008) Rosiglitazone, a PPAR gamma agonist, attenuates inflammation after surgical brain injury in rodents. Brain Res 1215:218\u2013224","journal-title":"Brain Res"},{"key":"1122_CR137","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1155\/2008\/864140","volume":"2008","author":"A Bernardo","year":"2008","unstructured":"Bernardo A, Minghetti L (2008) Regulation of glial cell functions by PPAR-gamma natural and synthetic agonists. PPAR Res 2008:864\u2013140","journal-title":"PPAR Res"},{"key":"1122_CR138","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/jcbfm.2009.221","volume":"30","author":"R Kumari","year":"2010","unstructured":"Kumari R, Willing LB, Patel SD, Krady JK, Zavadoski WJ, Gibbs EM, Vannucci SJ, Simpson IA (2010) The PPAR-gamma agonist, darglitazone, restores acute inflammatory responses to cerebral hypoxia-ischemia in the diabetic ob\/ob mouse. J Cereb Blood Flow Metab 30:352\u2013360","journal-title":"J Cereb Blood Flow Metab"},{"key":"1122_CR139","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1155\/2008\/295784","volume":"2008","author":"F Malchiodi-Albedi","year":"2008","unstructured":"Malchiodi-Albedi F, Matteucci A, Bernardo A, Minghetti L (2008) PPAR-gamma, microglial cells, and ocular inflammation: new venues for potential therapeutic approaches. PPAR Res 2008:295\u2013784","journal-title":"PPAR Res"},{"key":"1122_CR140","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1086\/605431","volume":"49","author":"AK Boggild","year":"2009","unstructured":"Boggild AK, Krudsood S, Patel SN, Serghides L, Tangpukdee N, Katz K, Wilairatana P, Liles WC, Looareesuwan S, Kain KC (2009) Use of peroxisome proliferator-activated receptor gamma agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis 49:841\u2013849","journal-title":"Clin Infect Dis"},{"key":"1122_CR141","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/NEN.0b013e3181aba2c1","volume":"68","author":"A Bernardo","year":"2009","unstructured":"Bernardo A, Bianchi D, Magnaghi V, Minghetti L (2009) Peroxisome proliferator-activated receptor-gamma agonists promote differentiation and antioxidant defenses of oligodendrocyte progenitor cells. J Neuropathol Exp Neurol 68:97\u2013808","journal-title":"J Neuropathol Exp Neurol"},{"key":"1122_CR142","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neuint.2006.03.020","volume":"49","author":"S Sundararajan","year":"2006","unstructured":"Sundararajan S, Jiang Q, Heneka M, Landreth G (2006) PPARgamma as a therapeutic target in central nervous system diseases. Neurochem Int 49:136\u2013144","journal-title":"Neurochem Int"},{"key":"1122_CR143","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1158\/1535-7163.MCT-09-0214","volume":"8","author":"H Kwak","year":"2009","unstructured":"Kwak H, Hwang I, Kim JH, Kim MY, Yang JS, Jeong S (2009) Modulation of transcription by the peroxisome proliferator-activated receptor \u03b2\/\u03b3\u2013binding RNA aptamer in colon cancer cells. Mol Cancer Ther 8:2664\u20132673","journal-title":"Mol Cancer Ther"},{"key":"1122_CR144","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1189\/jlb.0508284","volume":"86","author":"L Piqueras","year":"2009","unstructured":"Piqueras L, Sanz MJ, Perretti M, Morcillo E, Norling L, Mitchell JA, Li Y, Bishop-Bailey D (2009) Activation of PPAR \/\u03b2\/\u03b4 inhibits leukocyte recruitment, cell adhesion molecule expression, and chemokine release. J Leukoc Biol 86:115\u2013122","journal-title":"J Leukoc Biol"},{"key":"1122_CR145","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1038\/jid.2008.32","volume":"128","author":"N al Yacoub","year":"2008","unstructured":"al Yacoub N, Romanowska M, Krauss S, Schweiger S, Foerster J (2008) PPARdelta is a type 1 IFN target gene and inhibits apoptosis in T cells. J Invest Dermatol 128:1940\u20131949","journal-title":"J Invest Dermatol"},{"key":"1122_CR146","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1161\/01.ATV.0000250972.83623.61","volume":"27","author":"L Piqueras","year":"2007","unstructured":"Piqueras L, Reynolds AR, Hodivala-Dilke KM, Alfranca A, Redondo JM, Hatae T, Tanabe T, Warner TD, Bishop-Bailey D (2007) Activation of PPARbeta\/delta induces endothelial cell proliferation and angiogenesis. Arterioscler Thromb Vasc Biol 27:63\u201369","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1122_CR147","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.yjmcc.2006.03.422","volume":"40","author":"G Ding","year":"2006","unstructured":"Ding G, Cheng L, Qin Q, Frontin S, Yang Q (2006) PPARdelta modulates lipopolysaccharide-induced TNFalpha inflammation signaling in cultured cardiomyocytes. J Mol Cell Cardiol 40:821\u2013828","journal-title":"J Mol Cell Cardiol"},{"key":"1122_CR148","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1038\/sj.emboj.7600437","volume":"23","author":"NS Tan","year":"2004","unstructured":"Tan NS, Michalik L, Di-Po\u00ef N, Ng CY, Mermod N, Roberts AB, Desvergne B, Wahli W (2004) Essential role of Smad3 in the inhibition of inflammation-induced PPARbeta\/delta expression. EMBO J 23:4211\u20134221","journal-title":"EMBO J"},{"key":"1122_CR149","first-page":"7","volume":"18","author":"M Galuppo","year":"2010","unstructured":"Galuppo M, di Paola R, Mazzon E, Genovese T, Crisafulli C, Paterniti I, Cuzzocrea E, Bramanti P, Kapoor A, Thiemermann C, Cuzzocrea S (2010) Role of PPAR-\u03b2\/\u03b4 in the development of zymosan-induced multiple organ failure: an experiment mice study. J Inflamm Lond 18:7\u201312","journal-title":"J Inflamm Lond"},{"key":"1122_CR150","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2174\/156720509789207949","volume":"6","author":"S Kalinin","year":"2009","unstructured":"Kalinin S, Richardson JC, Feinstein DL (2009) A PPAR \u03b2\/\u03b4 agonist reduces amyloid burden and brain inflammation in a transgenic mouse model of Alzheimer's disease. Curr Alzheimer Res 6:431\u2013437","journal-title":"Curr Alzheimer Res"},{"key":"1122_CR151","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s00011-007-7157-4","volume":"57","author":"Z Haskova","year":"2008","unstructured":"Haskova Z, Hoang B, Luo G, Morgan LA, Billin AN, Barone FC, Shearer BG, Barton ME, Kilgore KS (2008) Modulation of LPS-induced pulmonary neutrophil infiltration and cytokine production by the selective PPAR \/\u03b2\/\u03b4 ligand GW0742. Inflamm Res 57:314\u2013321","journal-title":"Inflamm Res"},{"key":"1122_CR152","first-page":"6","volume":"7","author":"A Defaux","year":"2009","unstructured":"Defaux A, Zurich MG, Braissant O, Honegger P, Monnet-Tschudi F (2009) Effects of the PPAR-beta agonist GW501516 in an in vitro model of brain inflammation and antibody-induced demyelination. J Neuroinflammation 7:6\u201315","journal-title":"J Neuroinflammation"},{"key":"1122_CR153","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.2337\/db08-0176","volume":"57","author":"R Rodr\u00edguez-Calvo","year":"2008","unstructured":"Rodr\u00edguez-Calvo R, Serrano L, Coll T, Moullan N, S\u00e1nchez RM, Merlos M, Palomer X, Laguna JC, Michalik L, Wahli W, V\u00e1zquez-Carrera M (2008) Activation of peroxisome proliferator-activated receptor \u03b2\/\u03b4 inhibits lipopolysaccharide-induced cytokine production in adipocytes by lowering nuclear factor-kappaB activity via extracellular signal-related kinase \u00bd. Diabetes 57:2149\u20132157","journal-title":"Diabetes"},{"key":"1122_CR154","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1182\/blood-2009-06-226415","volume":"114","author":"AK Tripathi","year":"2009","unstructured":"Tripathi AK, Sha W, Shulaev V, Stins MF, Sullivan DJ Jr (2009) Plasmodium falciparum-infected erythrocytes induce NF-kappaB regulated inflammatory pathways in human cerebral endothelium. Blood 114:4243\u20134252","journal-title":"Blood"},{"key":"1122_CR155","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejphar.2009.09.002","volume":"622","author":"HJ Lim","year":"2009","unstructured":"Lim HJ, Park JH, Lee S, Choi HE, Lee KS, Park HY (2009) PPARdelta ligand L-165041 ameliorates Western diet-induced hepatic lipid accumulation and inflammation in LDLR-\/- mice. Eur J Pharmacol 622:45\u201351","journal-title":"Eur J Pharmacol"},{"key":"1122_CR156","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/10641960801945840","volume":"30","author":"L Sheng","year":"2008","unstructured":"Sheng L, Ye P, Liu YX, Han CG, Zhang ZY (2008) Peroxisome proliferator-activated receptor \u03b2\/\u03b4 activation improves angiotensin II-induced cardiac hypertrophy in vitro. Clin Exp Hypertens 30:109\u2013119","journal-title":"Clin Exp Hypertens"},{"key":"1122_CR157","doi-asserted-by":"crossref","unstructured":"Kanakasabai S, Chearwae W, Walline CC, Iams W, Adams SM, Bright JJ (2010) Peroxisome proliferator-activated receptor delta agonists inhibit T helper type 1 (Th1) and Th17 responses in experimental allergic encephalomyelitis. Immunology 130(4):572\u2013588","DOI":"10.1111\/j.1365-2567.2010.03261.x"},{"key":"1122_CR158","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1073\/pnas.012610299","volume":"99","author":"Y Barak","year":"2002","unstructured":"Barak Y, Liao D, He W, Ong ES, Nelson MC, Olefsky JM, Boland R, Evans RM (2002) Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer. Proc Natl Acad Sci USA 99:303\u2013308","journal-title":"Proc Natl Acad Sci USA"},{"key":"1122_CR159","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1242\/dmm.003913","volume":"10","author":"TT Schug","year":"2009","unstructured":"Schug TT, Li X (2009) PPAR delta-mediated macrophage activation: a matter of fat. Dis Model Mech 10:421\u2013422","journal-title":"Dis Model Mech"},{"key":"1122_CR160","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1073\/pnas.0711875105","volume":"105","author":"GD Barish","year":"2008","unstructured":"Barish GD, Atkins AR, Downes M, Olson P, Chong LW, Nelson M, Zou Y, Hwang H, Kang H, Curtiss L, Evans RM, Lee CH (2008) PPARdelta regulates multiple proinflammatory pathways to suppress atherosclerosis. Proc Natl Acad Sci USA 105:4271\u20134276","journal-title":"Proc Natl Acad Sci USA"},{"key":"1122_CR161","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1073\/pnas.0708647105","volume":"105","author":"Y Takata","year":"2008","unstructured":"Takata Y, Liu J, Yin F, Collins AR, Lyon CJ, Lee CH, Atkins AR, Downes M, Barish GD, Evans RM, Hsueh WA, Tangirala RK (2008) PPARdelta-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis. Proc Natl Acad Sci USA 105:4277\u20134282","journal-title":"Proc Natl Acad Sci USA"},{"key":"1122_CR162","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/CIRCRESAHA.108.189159","volume":"105","author":"HJ Kim","year":"2009","unstructured":"Kim HJ, Kim MY, Jin H, Kim HJ, Kang SS, Kim HJ, Lee JH, Chang KC, Hwang JY, Yabe-Nishimura C, Kim JH, Seo HG (2009) Peroxisome proliferator-activated receptor delta regulates extracellular matrix and apoptosis of vascular smooth muscle cells through the activation of transforming growth factor-{beta}1\/Smad3. Circ Res 105:16\u201324","journal-title":"Circ Res"},{"key":"1122_CR163","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1096\/fj.05-4395fje","volume":"20","author":"FY Ali","year":"2006","unstructured":"Ali FY, Davidson SJ, Moraes LA, Traves SL, Paul-Clark M, Bishop-Bailey D, Warner TD, Mitchell JA (2006) Role of nuclear receptor signaling in platelets: antithrombotic effects of PPARbeta. FASEB J 20:326\u2013328","journal-title":"FASEB J"},{"key":"1122_CR164","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1165\/rcmb.2005-0289OC","volume":"34","author":"FY Ali","year":"2006","unstructured":"Ali FY, Egan K, FitzGerald GA, Desvergne B, Wahli W, Bishop-Bailey D, Warner TD, Mitchell JA (2006) Role of prostacyclin versus peroxisome proliferator-activated receptor beta receptors in prostacyclin sensing by lung fibroblasts. Am J Respir Cell Mol Biol 34:242\u2013246","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1122_CR165","doi-asserted-by":"crossref","first-page":"8992","DOI":"10.1038\/sj.onc.1208143","volume":"23","author":"KR Reed","year":"2004","unstructured":"Reed KR, Sansom OJ, Hayes AJ, Gescher AJ, Winton DJ, Peters JM, Clarke AR (2004) PPARdelta status and Apc-mediated tumourigenesis in the mouse intestine. Oncogene 23:8992\u20138996","journal-title":"Oncogene"},{"key":"1122_CR166","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/nm.2048","volume":"15","author":"L Mukundan","year":"2009","unstructured":"Mukundan L, Odegaard JI, Morel CR, Heredia JE, Mwangi JW, Ricardo-Gonzalez RR, Goh YP, Eagle AR, Dunn SE, Awakuni JU, Nguyen KD, Steinman L, Michie SA, Chawla A (2009) PPAR-delta senses and orchestrates clearance of apoptotic cells to promote tolerance. Nat Med 15:1266\u20131272","journal-title":"Nat Med"},{"key":"1122_CR167","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/toxsci\/kfn142","volume":"105","author":"W Shan","year":"2008","unstructured":"Shan W, Palkar PS, Murray IA, McDevitt EI, Kennett MJ, Kang BH, Isom HC, Perdew GH, Gonzalez FJ, Peters JM (2008) Ligand activation of peroxisome proliferator-activated receptor \u03b2\/\u03b4 (PPAR\u03b2\/\u03b3) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression. Toxicol Sci 105:418\u2013428","journal-title":"Toxicol Sci"},{"key":"1122_CR168","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.2353\/ajpath.2010.090691","volume":"176","author":"P Cabrales","year":"2010","unstructured":"Cabrales P, Zanini GM, Meays D, Frangos JA, Carvalho LJ (2010) Murine cerebral malaria is associated with a vasospasm-like microcirculatory dysfunction, and survival upon rescue treatment is markedly increased by nimodipine. Am J Pathol 176:1306\u20131315","journal-title":"Am J Pathol"},{"issue":"2008","key":"1122_CR169","doi-asserted-by":"crossref","first-page":"780452","DOI":"10.1155\/2008\/780452","volume":"2008","author":"MG Hall","year":"2008","unstructured":"Hall MG, Quignodon L, Desvergne B (2008) Peroxisome proliferator-activated receptor \/\u03b2\/\u03b4 in the brain: facts and hypothesis. PPAR Res 2008(2008):780452","journal-title":"PPAR Res"},{"key":"1122_CR170","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2174\/1874467210902010046","volume":"2","author":"T Coll","year":"2009","unstructured":"Coll T, Rodr\u00efguez-Calvo R, Barroso E, Serrano L, Eyre E, Palomer X, V\u00e1zquez-Carrera M (2009) Peroxisome proliferator-activated receptor (PPAR) \/\u03b2\/\u03b4: a new potential therapeutic target for the treatment of metabolic syndrome. Curr Mol Pharmacol 2:46\u201355","journal-title":"Curr Mol Pharmacol"},{"key":"1122_CR171","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.mehy.2005.01.040","volume":"65","author":"A Erol","year":"2005","unstructured":"Erol A (2005) PPARalpha activators may be good candidates as anti-aging agents. Med Hypotheses 65:35\u201338","journal-title":"Med Hypotheses"},{"key":"1122_CR172","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.phrs.2009.03.020","volume":"60","author":"TH Huang","year":"2009","unstructured":"Huang TH, Teoh AW, Lin BL, Lin DS, Roufogalis B (2009) The role of herbal PPAR modulators in the treatment of cardiometabolic syndrome. Pharmacol Res 60:195\u2013206","journal-title":"Pharmacol Res"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-010-1122-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-010-1122-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-010-1122-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T15:01:12Z","timestamp":1740754872000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-010-1122-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,9]]},"references-count":172,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["1122"],"URL":"https:\/\/doi.org\/10.1007\/s10096-010-1122-9","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,9]]}}}